| Jul 24 |
Alkermes beats top-line and bottom-line estimates; reaffirms FY24 outlook
|
| Jul 24 |
Alkermes plc Reports Second Quarter 2024 Financial Results
|
| Jul 23 |
Alkermes Q2 2024 Earnings Preview
|
| Jul 19 |
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
|
| Jul 17 |
Alkermes to Report Second Quarter Financial Results on July 24, 2024
|
| Jul 17 |
Alkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q2 Release
|
| Jul 15 |
6 Analysts Assess Alkermes: What You Need To Know
|
| Jun 24 |
Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
|
| Jun 3 |
Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024
|
| May 31 |
Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
|
